Drug recall D-0246-2026
Product
Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13
Reason for recall
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Lots and codes
Lot #: 19251311, Exp Date April 2027
Recall details
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ
- Quantity
- 96,948 packs
- Distribution
- Nationwide within the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- December 30, 2025
Related products
- Ondansetron – drug information
- NDC 68462-157 Ondansetron · Ondansetron 4 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-158 Ondansetron · Ondansetron 8 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-105 Ondansetron · Ondansetron Hydrochloride 4 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-106 Ondansetron · Ondansetron Hydrochloride 8 mg/1 · Glenmark Pharmaceuticals Inc., USA